<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01507493</url>
  </required_header>
  <id_info>
    <org_study_id>SCN9A</org_study_id>
    <nct_id>NCT01507493</nct_id>
  </id_info>
  <brief_title>The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population</brief_title>
  <official_title>The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xianwei Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was conducted to explore whether the non-synonymous single-nucleotide
      polymorphisms in SCN9A gene can predict individual basal pain perception and postoperative
      pain intensity in the general population undergoing upper abdominal surgery. Methods:
      Patients receiving elective upper abdominal surgery under general anesthesia were recruited
      into this study. Genotyping of SCN9A was carried out by direct sequencing. The investigators
      measured their preoperative pressure pain threshold (PPT) and pressure pain tolerance (PTO).
      The visual analog scale (VAS) was used for pain evaluation at rest during patient-controlled
      analgesia (PCA) treatment 0 h, 12 h ,24 h and 48h after operation. And the PCA press
      frequency and drug consumption were recorded.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with the following diseases were excluded: known history of chronic pain,
      psychiatric diseases or communication disorders, diabetes mellitus, severe cardiovascular
      diseases, kidney or liver diseases with poor hepatic function, alcohol or drug abuse, heavy
      smoker, pregnancy or at the lactation period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Opioid Consumption Dose 48h After Operation.</measure>
    <time_frame>48 hours after the operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PCA Press Frequency 48h After Operation.</measure>
    <time_frame>48 hours after the operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Visual Analog Scale 48h After Operation.</measure>
    <time_frame>48 hours after the operation</time_frame>
    <description>The visual analog scale (VAS) is used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 48h after operation. And the visual analog scale is from 0 to 10 which 0 represent no pain while 10 represent unbearable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative Pressure Pain Threshold (PPT)</measure>
    <time_frame>12 hours before the operation</time_frame>
    <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say &quot;pain&quot; when they started to feel pain during the stimulation. The value from the LCD was recorded as the pressure pain threshold.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative Pressure Pain Tolerance (PTO)</measure>
    <time_frame>12 hours before the operation</time_frame>
    <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say &quot;ok&quot; when they started to feel the pain became intolerable during the stimulation. The value from the LCD was recorded as the pressure pain tolerance.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Pain</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>mutant alleles</arm_group_label>
    <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>wild-type alleles</arm_group_label>
    <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Heparin anti-coagulated blood (2 ml) was collected from the central venous during the
      operation and all blood samples were stored at -80℃. Genomic DNA was extracted from the blood
      samples using a guanidinium isothiocyanate method.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        800 Chinese patients receiving elective upper abdominal surgery under general anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 20-70 years

          -  Receiving elective upper abdominal surgery

          -  Anesthesiologists (ASA) physical status I or II

          -  Received PCA administration

          -  Agreed to participate the research

        Exclusion Criteria:

          -  History of chronic pain

          -  Psychiatric diseases

          -  Diabetes mellitus

          -  Severe cardiovascular diseases

          -  Kidney or liver diseases

          -  Alcohol or drug abuse

          -  Heavy smoker

          -  Pregnancy or at lactation period

          -  Refused PCA administration

          -  Disagree to participate to the research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhang Xianwei, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2012</study_first_submitted>
  <study_first_submitted_qc>January 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2012</study_first_posted>
  <results_first_submitted>May 30, 2013</results_first_submitted>
  <results_first_submitted_qc>August 31, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 3, 2014</results_first_posted>
  <last_update_submitted>August 31, 2014</last_update_submitted>
  <last_update_submitted_qc>August 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Xianwei Zhang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>gene polymorphism</keyword>
  <keyword>SCN9A</keyword>
  <keyword>pain perception</keyword>
  <keyword>postoperative pain</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mutant Alleles</title>
          <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
        </group>
        <group group_id="P2">
          <title>Wild-type Alleles</title>
          <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="178"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="178"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Mutant Alleles</title>
          <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
        </group>
        <group group_id="B2">
          <title>Wild-type Alleles</title>
          <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="178"/>
            <count group_id="B3" value="200"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.9" spread="9.3"/>
                    <measurement group_id="B2" value="55.6" spread="5.3"/>
                    <measurement group_id="B3" value="55.2" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="101"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="178"/>
                    <measurement group_id="B3" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption Dose 48h After Operation.</title>
        <time_frame>48 hours after the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mutant Alleles</title>
            <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
          </group>
          <group group_id="O2">
            <title>Wild-type Alleles</title>
            <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption Dose 48h After Operation.</title>
          <units>microgramme</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.4" spread="10.4"/>
                    <measurement group_id="O2" value="50.4" spread="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Visual Analog Scale 48h After Operation.</title>
        <description>The visual analog scale (VAS) is used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 48h after operation. And the visual analog scale is from 0 to 10 which 0 represent no pain while 10 represent unbearable pain</description>
        <time_frame>48 hours after the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mutant Alleles</title>
            <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
          </group>
          <group group_id="O2">
            <title>Wild-type Alleles</title>
            <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
          </group>
        </group_list>
        <measure>
          <title>The Visual Analog Scale 48h After Operation.</title>
          <description>The visual analog scale (VAS) is used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 48h after operation. And the visual analog scale is from 0 to 10 which 0 represent no pain while 10 represent unbearable pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="2.5"/>
                    <measurement group_id="O2" value="5.0" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Preoperative Pressure Pain Threshold (PPT)</title>
        <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say “pain” when they started to feel pain during the stimulation. The value from the LCD was recorded as the pressure pain threshold.</description>
        <time_frame>12 hours before the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mutant Alleles</title>
            <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
          </group>
          <group group_id="O2">
            <title>Wild-type Alleles</title>
            <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
          </group>
        </group_list>
        <measure>
          <title>Preoperative Pressure Pain Threshold (PPT)</title>
          <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say “pain” when they started to feel pain during the stimulation. The value from the LCD was recorded as the pressure pain threshold.</description>
          <units>kg/cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="1.0"/>
                    <measurement group_id="O2" value="3.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PCA Press Frequency 48h After Operation.</title>
        <time_frame>48 hours after the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mutant Alleles</title>
            <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
          </group>
          <group group_id="O2">
            <title>Wild-type Alleles</title>
            <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
          </group>
        </group_list>
        <measure>
          <title>PCA Press Frequency 48h After Operation.</title>
          <units>presses per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="5.6"/>
                    <measurement group_id="O2" value="19.9" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Preoperative Pressure Pain Tolerance (PTO)</title>
        <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say “ok” when they started to feel the pain became intolerable during the stimulation. The value from the LCD was recorded as the pressure pain tolerance.</description>
        <time_frame>12 hours before the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mutant Alleles</title>
            <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
          </group>
          <group group_id="O2">
            <title>Wild-type Alleles</title>
            <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
          </group>
        </group_list>
        <measure>
          <title>Preoperative Pressure Pain Tolerance (PTO)</title>
          <description>The probe of pressure algometer was positioned perpendicularly to the skin surface of the patient, and the investigator applied continuous pressure at approximately the same rate according to the visual LCD display on the algometer. subjects were asked to say “ok” when they started to feel the pain became intolerable during the stimulation. The value from the LCD was recorded as the pressure pain tolerance.</description>
          <units>kg/cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="3.6"/>
                    <measurement group_id="O2" value="6.5" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Mutant Alleles</title>
          <description>grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.</description>
        </group>
        <group group_id="E2">
          <title>Wild-type Alleles</title>
          <description>grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Xianwei Zhang</name_or_title>
      <organization>Huazhong University of Science&amp;Technology</organization>
      <phone>13037154560</phone>
      <email>znpain@sina.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

